Belite Bio, Inc Ratios

Ratios Dec2020 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 27,390.48%79,050.00%126,492.00%180,690.00%
EBIT Margin 27,347.62%80,131.25%126,672.00%199,980.00%
EBITDA Margin 27,366.67%80,275.00%126,456.00%182,150.00%
Operating Margin 27,347.62%80,131.25%126,672.00%199,980.00%
Net Margin 27,395.24%79,050.00%126,528.00%180,720.00%
FCF Margin 21,152.38%74,075.00%119,600.00%146,750.00%
Leverage & Solvency
Interest Coverage Ratio -273.48-801.31-0.00M-0.00M
Times Interest Earned -273.48-801.31-0.00M-0.00M
Valuation
Enterprise Value 726.35M1,139.13M1,839.33M
Market Capitalization 726.35M1,139.13M1,839.33M
Return Ratios
Return on Sales 273.95%790.50%